Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2015

01.04.2015 | Clinical Study

Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma

verfasst von: Kristen W. Yeom, Robert M. Lober, Marvin D. Nelson Jr., Ashok Panigrahy, Stefan Blüml

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Citrate, a tricarboxylic acid cycle intermediate, is present in high concentrations in pediatric diffuse intrinsic pontine gliomas (DIPG). Since citrate increases during hypoxia in animal studies, we hypothesized that it accumulates in DIPG when hypoperfused. Relative tumor blood volumes (rTBV) were determined, using dynamic susceptibility contrast-enhanced magnetic resonance imaging, in twelve children [median age 8.2 (range 3.2–14.5) years] with DIPG and compared to citrate concentrations measured with in vivo proton magnetic resonance spectroscopy (1H MRS). Tissue perfusion and metabolite concentration were assessed at initial presentation and over the clinical course, yielding 36 and 46 perfusion and MR spectroscopy datasets, respectively. At presentation, DIPG blood volume was 60 ± 27 % of that measured for normal cerebellum. Citrate, which is not detectable in normal brain tissue, was present in DIPG at concentrations of 3.81 ± 1.44 mmol/kg tissue. Over the course of the disease and treatment, rTBV increased and citrate decreased (both p < 0.05) with an inverse correlation (p = 0.028). Citrate accumulation is associated with tissue hypoperfusion in DIPG.
Literatur
1.
Zurück zum Zitat Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241–248CrossRefPubMed Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241–248CrossRefPubMed
2.
Zurück zum Zitat Seymour ZA, Panigrahy A, Finlay JL, Nelson MD Jr, Bluml S (2008) Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol 29(5):1006–1011CrossRefPubMed Seymour ZA, Panigrahy A, Finlay JL, Nelson MD Jr, Bluml S (2008) Citrate in pediatric CNS tumors? AJNR Am J Neuroradiol 29(5):1006–1011CrossRefPubMed
3.
Zurück zum Zitat Choi C, Ganji SK, Madan A, Hulsey KM, An Z, Zhang S, Pinho MC, Deberardinis RJ, Bachoo RM, Maher EA (2013) In vivo detection of citrate in brain tumors by (1)H magnetic resonance spectroscopy at 3T. Magn Reson Med 72(2):316–323CrossRefPubMed Choi C, Ganji SK, Madan A, Hulsey KM, An Z, Zhang S, Pinho MC, Deberardinis RJ, Bachoo RM, Maher EA (2013) In vivo detection of citrate in brain tumors by (1)H magnetic resonance spectroscopy at 3T. Magn Reson Med 72(2):316–323CrossRefPubMed
4.
Zurück zum Zitat Rafałowska U (1979) Transport of malate and citrate into rat brain mitochondria under hypoxia and anesthesia. Neurochem Res 4(3):355–364CrossRefPubMed Rafałowska U (1979) Transport of malate and citrate into rat brain mitochondria under hypoxia and anesthesia. Neurochem Res 4(3):355–364CrossRefPubMed
5.
Zurück zum Zitat Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS Jr (1998) Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 19(3):535–540PubMed Hwang JH, Egnaczyk GF, Ballard E, Dunn RS, Holland SK, Ball WS Jr (1998) Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas. AJNR Am J Neuroradiol 19(3):535–540PubMed
6.
Zurück zum Zitat Panigrahy A, Krieger MD, Gonzalez-Gomez I, Liu X, McComb JG, Finlay JL, Nelson MD Jr, Gilles FH, Bluml S (2006) Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol 27(3):560–572PubMed Panigrahy A, Krieger MD, Gonzalez-Gomez I, Liu X, McComb JG, Finlay JL, Nelson MD Jr, Gilles FH, Bluml S (2006) Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. AJNR Am J Neuroradiol 27(3):560–572PubMed
7.
Zurück zum Zitat Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA (1996) Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84(3):449–458CrossRefPubMed Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA (1996) Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84(3):449–458CrossRefPubMed
8.
Zurück zum Zitat Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, Tomandl B, Moser E, Ganslandt O (2006) Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 238(3):958–969CrossRefPubMed Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, Tomandl B, Moser E, Ganslandt O (2006) Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 238(3):958–969CrossRefPubMed
9.
Zurück zum Zitat Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87(4):516–524CrossRefPubMed Tedeschi G, Lundbom N, Raman R, Bonavita S, Duyn JH, Alger JR, Di Chiro G (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87(4):516–524CrossRefPubMed
10.
Zurück zum Zitat Shimizu H, Kumabe T, Shirane R, Yoshimoto T (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21(4):659–665PubMed Shimizu H, Kumabe T, Shirane R, Yoshimoto T (2000) Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21(4):659–665PubMed
11.
Zurück zum Zitat Sorensen AG, Reimer P (2000) Cerebral MR perfusion imaging. Principles and current applications. Thieme, Stuttgart Sorensen AG, Reimer P (2000) Cerebral MR perfusion imaging. Principles and current applications. Thieme, Stuttgart
12.
Zurück zum Zitat Essig M, Nguyen TB, Shiroishi MS, Saake M, Provenzale JM, Enterline DS, Anzalone N, Dörfler A, Rovira À, Wintermark M, Law M (2013) Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol 201(3):W495–W510CrossRefPubMed Essig M, Nguyen TB, Shiroishi MS, Saake M, Provenzale JM, Enterline DS, Anzalone N, Dörfler A, Rovira À, Wintermark M, Law M (2013) Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol 201(3):W495–W510CrossRefPubMed
13.
Zurück zum Zitat Panigrahy A, Nelson MD Jr, Finlay JL, Sposto R, Krieger MD, Gilles FH, Bluml S (2008) Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol 10(1):32–44CrossRefPubMedCentralPubMed Panigrahy A, Nelson MD Jr, Finlay JL, Sposto R, Krieger MD, Gilles FH, Bluml S (2008) Metabolism of diffuse intrinsic brainstem gliomas in children. Neuro Oncol 10(1):32–44CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211(3):791–798CrossRefPubMed Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 211(3):791–798CrossRefPubMed
15.
Zurück zum Zitat Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171(6):1479–1486CrossRefPubMed Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171(6):1479–1486CrossRefPubMed
16.
Zurück zum Zitat Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191(1):41–51CrossRefPubMed Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191(1):41–51CrossRefPubMed
17.
Zurück zum Zitat Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G (2006) Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology 238(2):658–667CrossRefPubMed Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G (2006) Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging—prediction of patient clinical response. Radiology 238(2):658–667CrossRefPubMed
18.
Zurück zum Zitat Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38–47CrossRefPubMed Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38–47CrossRefPubMed
19.
Zurück zum Zitat Busch H, Davis JR, Olle EW (1957) Citrate accumulation in slices of transplantable tumors of the rat. Cancer Res 17(7):711–716PubMed Busch H, Davis JR, Olle EW (1957) Citrate accumulation in slices of transplantable tumors of the rat. Cancer Res 17(7):711–716PubMed
20.
Zurück zum Zitat Vander Heiden M, Cantley L, Thompson C (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033CrossRefPubMedCentralPubMed Vander Heiden M, Cantley L, Thompson C (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ (2012) Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481(7381):385–388 Mullen AR, Wheaton WW, Jin ES, Chen PH, Sullivan LB, Cheng T, Yang Y, Linehan WM, Chandel NS, DeBerardinis RJ (2012) Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481(7381):385–388
23.
Zurück zum Zitat Icard P, Poulain L, Lincet H (2012) Understanding the central role of citrate in the metabolism of cancer cells. Biochim Biophys Acta 1825(1):111–116PubMed Icard P, Poulain L, Lincet H (2012) Understanding the central role of citrate in the metabolism of cancer cells. Biochim Biophys Acta 1825(1):111–116PubMed
24.
Zurück zum Zitat Blüml S, Panigrahy A, Laskov M, Dhall G, Krieger MD, Nelson MD, Finlay JL, Gilles FH (2011) Elevated citrate in pediatric astrocytomas with malignant progression. Neuro Oncol 13(10):1107–1117CrossRefPubMedCentralPubMed Blüml S, Panigrahy A, Laskov M, Dhall G, Krieger MD, Nelson MD, Finlay JL, Gilles FH (2011) Elevated citrate in pediatric astrocytomas with malignant progression. Neuro Oncol 13(10):1107–1117CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Riva C, Chauvin C, Pison C, Leverve X (1998) Cellular physiology and molecular events in hypoxia-induced apoptosis. Anticancer Res 18(6B):4729–4736PubMed Riva C, Chauvin C, Pison C, Leverve X (1998) Cellular physiology and molecular events in hypoxia-induced apoptosis. Anticancer Res 18(6B):4729–4736PubMed
26.
Zurück zum Zitat Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379(6560):88–91CrossRefPubMed Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379(6560):88–91CrossRefPubMed
27.
Zurück zum Zitat Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35(2):71–103CrossRefPubMed Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35(2):71–103CrossRefPubMed
28.
Zurück zum Zitat Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843–845CrossRefPubMed Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843–845CrossRefPubMed
29.
Zurück zum Zitat Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Giaccia AJ (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14(9):6264–6277CrossRefPubMedCentralPubMed Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ, Giaccia AJ (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14(9):6264–6277CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24(2):68–72CrossRefPubMed Dang CV, Semenza GL (1999) Oncogenic alterations of metabolism. Trends Biochem Sci 24(2):68–72CrossRefPubMed
31.
Zurück zum Zitat Rice GC, Hoy C, Schimke RT (1986) Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83(16):5978–5982CrossRefPubMedCentralPubMed Rice GC, Hoy C, Schimke RT (1986) Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83(16):5978–5982CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat Höckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266–276CrossRefPubMed Höckel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266–276CrossRefPubMed
33.
Zurück zum Zitat Young SD, Marshall RS, Hill RP (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85(24):9533–9537CrossRefPubMedCentralPubMed Young SD, Marshall RS, Hill RP (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 85(24):9533–9537CrossRefPubMedCentralPubMed
34.
Zurück zum Zitat Jang A, Hill RP (1997) An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis 15(5):469–483CrossRefPubMed Jang A, Hill RP (1997) An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin Exp Metastasis 15(5):469–483CrossRefPubMed
35.
Zurück zum Zitat Hasan NM, Adams GE, Joiner MC, Marshall JF, Hart IR (1998) Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability. Br J Cancer 77(11):1799–1805CrossRefPubMedCentralPubMed Hasan NM, Adams GE, Joiner MC, Marshall JF, Hart IR (1998) Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability. Br J Cancer 77(11):1799–1805CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat Sanna K, Rofstad EK (1994) Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro. Int J Cancer 58(2):258–262CrossRefPubMed Sanna K, Rofstad EK (1994) Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro. Int J Cancer 58(2):258–262CrossRefPubMed
37.
Zurück zum Zitat Wilson RE, Keng PC, Sutherland RM (1989) Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. J Natl Cancer Inst 81(16):1235–1240CrossRefPubMed Wilson RE, Keng PC, Sutherland RM (1989) Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia. J Natl Cancer Inst 81(16):1235–1240CrossRefPubMed
38.
Zurück zum Zitat Zhivotovsky B, Joseph B, Orrenius S (1999) Tumor radiosensitivity and apoptosis. Exp Cell Res 248(1):10–17CrossRefPubMed Zhivotovsky B, Joseph B, Orrenius S (1999) Tumor radiosensitivity and apoptosis. Exp Cell Res 248(1):10–17CrossRefPubMed
39.
Zurück zum Zitat Sedlacik J, Winchell A, Kocak M, Loeffler RB, Broniscer A, Hillenbrand CM (2013) MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 34(7):1450–1455CrossRefPubMedCentralPubMed Sedlacik J, Winchell A, Kocak M, Loeffler RB, Broniscer A, Hillenbrand CM (2013) MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma. AJNR Am J Neuroradiol 34(7):1450–1455CrossRefPubMedCentralPubMed
40.
Zurück zum Zitat Poussaint TY, Kocak M, Vajapeyam S, Packer RI, Robertson RL, Geyer R, Haas-Kogan D, Pollack IF, Vezina G, Zimmerman R, Cha S, Patay Z, Boyett JM, Kun LE (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol 13(4):417–427CrossRefPubMedCentralPubMed Poussaint TY, Kocak M, Vajapeyam S, Packer RI, Robertson RL, Geyer R, Haas-Kogan D, Pollack IF, Vezina G, Zimmerman R, Cha S, Patay Z, Boyett JM, Kun LE (2011) MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC). Neuro Oncol 13(4):417–427CrossRefPubMedCentralPubMed
41.
Zurück zum Zitat Lober RM, Cho YJ, Tang Y, Barnes PD, Edwards MS, Vogel H, Fisher PG, Monje M, Yeom KW (2014) Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. J Neurooncol 117(1):175–182CrossRefPubMed Lober RM, Cho YJ, Tang Y, Barnes PD, Edwards MS, Vogel H, Fisher PG, Monje M, Yeom KW (2014) Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma. J Neurooncol 117(1):175–182CrossRefPubMed
42.
Zurück zum Zitat Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, Bourgey M, Bourque G, Montpetit A, Bourret G, Lepage P, Fleming A, Lichter P, Kool M, von Deimling A, Sturm D, Korshunov A, Faury D, Jones DT, Majewski J, Pfister SM, Jabado N, Hawkins C (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124(3):439–447CrossRefPubMedCentralPubMed Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, Bourgey M, Bourque G, Montpetit A, Bourret G, Lepage P, Fleming A, Lichter P, Kool M, von Deimling A, Sturm D, Korshunov A, Faury D, Jones DT, Majewski J, Pfister SM, Jabado N, Hawkins C (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124(3):439–447CrossRefPubMedCentralPubMed
Metadaten
Titel
Citrate concentrations increase with hypoperfusion in pediatric diffuse intrinsic pontine glioma
verfasst von
Kristen W. Yeom
Robert M. Lober
Marvin D. Nelson Jr.
Ashok Panigrahy
Stefan Blüml
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2015
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-015-1726-0

Weitere Artikel der Ausgabe 2/2015

Journal of Neuro-Oncology 2/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.